Xenglu-Lin (10/5Mg) 14 Tablets
Xenglu-Lin 10/5mg Tablets contain empagliflozin and linagliptin for adult type 2 diabetes management. This oral antidiabetic combination supports blood glucose control when used with diet, exercise and physician-directed monitoring.
₨ 504 – ₨ 715Price range: ₨ 504 through ₨ 715
Overview
Xenglu-Lin 10/5mg Tablets are an oral antidiabetic medicine used for the management of type 2 diabetes mellitus in adults. Each tablet contains two complementary active ingredients: empagliflozin 10mg and linagliptin 5mg. Empagliflozin belongs to the sodium-glucose co-transporter 2 inhibitor class, while linagliptin belongs to the dipeptidyl peptidase-4 inhibitor class.
This medicine is intended for patients who require dual oral therapy for blood sugar control. It is not a substitute for lifestyle measures, insulin where clinically required, or regular diabetes monitoring. Blood glucose, kidney function, hydration status and other risk factors should be reviewed by a healthcare professional before and during treatment.
Benefits
- Helps improve glycaemic control in adults with type 2 diabetes
- Supports blood glucose management through complementary mechanisms
- Can be used with diet and exercise as part of a diabetes care plan
- May help reduce long-term diabetes complication risk through improved blood sugar control
Key Features
- Contains empagliflozin 10mg plus linagliptin 5mg per tablet
- Oral antidiabetic combination for type 2 diabetes mellitus
- Dual SGLT2 inhibitor and DPP-4 inhibitor mechanism
- 14-tablet pack
- Use only as directed by a physician
Dosage and How to Use
- How to use: Swallow the tablet with water. Take at the same time each day, with or without food, and continue prescribed diet, exercise and glucose monitoring.
- Administration: Oral tablet; swallow whole with water unless advised otherwise by a healthcare professional.
- Recommended dose: Use exactly as prescribed by a physician. A common adult regimen for this combination strength is one 10mg/5mg tablet once daily in the morning.
- Adult dose: As prescribed; commonly one 10mg/5mg tablet once daily in the morning.
- Pediatric use: Safety and effectiveness in children and adolescents have not been established for this combination; use only if specifically prescribed by a specialist.
- Elderly use: Use with caution in elderly patients, especially those at risk of dehydration, low blood pressure, kidney impairment or recurrent infections.
- When to take: Usually once daily in the morning, as directed by the prescribing physician.
- With food: May be taken with or without food.
- Maximum daily dose: Do not exceed the dose prescribed by your doctor. For the empagliflozin/linagliptin combination, dose increases up to 25mg/5mg once daily may be considered only by a physician.
- Missed dose: Take the missed dose when remembered unless it is close to the next dose. Do not take two doses together to make up for a missed dose; follow your physician’s instructions.
- Overdose: Seek medical advice or emergency care immediately. Overdose may require monitoring and supportive treatment, especially for dehydration, low blood pressure, hypoglycaemia or electrolyte imbalance.
Specifications
| Brand | Hilton |
|---|---|
| Manufacturer | Hilton Pharma |
| Marketer / Distributor | Hilton Pharma (Pvt) Ltd |
| Country of Origin | Pakistan |
| Drug class | Sodium-glucose co-transporter 2 (SGLT2) inhibitor plus dipeptidyl peptidase-4 (DPP-4) inhibitor |
| Therapeutic category | Oral antidiabetic medicine |
| Age group | Adults |
| Suitable for | Adults with type 2 diabetes mellitus when prescribed by a healthcare professional. |
| Prescription required | Yes |
Side Effects
Common side effects
- Increased urination
- Thirst
- Urinary tract infection
- Genital fungal infection
- Stuffy or runny nose
- Sore throat
- Low blood sugar when used with insulin or sulfonylureas
Serious side effects (seek medical help)
- Diabetic ketoacidosis
- Severe dehydration or low blood pressure
- Pancreatitis
- Severe urinary tract infection
- Fournier’s gangrene
- Serious allergic reaction
- Severe joint pain
- Bullous pemphigoid or blistering skin reaction
- Heart failure symptoms
- Lower limb infection, ulcers or amputation risk
Allergic reaction
Stop the medicine and seek urgent help if rash, hives, swelling of the face/lips/tongue/throat, breathing difficulty, skin peeling or severe allergic symptoms occur.
Safety and Precautions
- Not for type 1 diabetes or diabetic ketoacidosis
- May increase risk of ketoacidosis, dehydration, urinary infections and genital fungal infections
- Risk of hypoglycaemia may increase when combined with insulin or insulin secretagogues
- Assess kidney function and hydration status as advised by a doctor
- Inform your doctor about kidney disease, liver disease, heart failure, pancreatitis history, recurrent urinary infections or planned surgery
- Maintain adequate hydration unless fluid restriction has been advised
- Monitor blood glucose regularly
- Report symptoms of urinary infection, genital infection, severe abdominal pain or unusual tiredness promptly
When not to use
Known hypersensitivity to empagliflozin, linagliptin or any tablet ingredient | Use in diabetic ketoacidosis | Severe renal impairment, end-stage renal disease or dialysis unless a specialist advises otherwise
Special populations
- Pregnancy: Use during pregnancy only on medical advice. Diabetes treatment may need specialist adjustment during pregnancy.
- Breastfeeding: Consult a doctor before use while breastfeeding; the suitability of this combination should be assessed by a healthcare professional.
- Fertility: No patient-specific fertility information is available for this product; consult a doctor if planning pregnancy.
- Liver: Use with medical supervision in patients with liver disease or heavy alcohol use.
- Kidney: Kidney function should be assessed before and during treatment. This medicine may be unsuitable in significant renal impairment or dialysis.
- Heart: Discuss use with a doctor if you have heart failure, low blood pressure, cardiovascular disease or dehydration risk.
- Driving: Use caution when driving or operating machinery if dizziness, dehydration or low blood sugar symptoms occur.
- Alcohol: Limit or avoid alcohol unless your doctor says it is safe, as alcohol may worsen dehydration, hypoglycaemia or ketoacidosis risk.
Interactions
Drugs:
- Insulin and sulfonylureas may increase hypoglycaemia risk
- Diuretics may increase dehydration or low blood pressure risk
- Other glucose-lowering medicines may require dose review
- Tell your doctor about all prescription, OTC and herbal medicines
Food:
- No specific food restriction is universally required, but follow the diabetes meal plan advised by your doctor or dietitian.
Conditions:
- Type 1 diabetes
- Renal impairment
- Pancreatitis history
- Recurrent urinary tract or genital infections
- Heart failure
- Dehydration or low blood pressure
- Planned surgery or prolonged fasting
Storage and Disposal
- Store in a cool, dry place away from direct sunlight, heat and moisture. Keep in original packaging until use.
- Store at room temperature; avoid excessive heat and moisture.
- Keep out of the reach and sight of children.
- Do not use expired or damaged tablets. Ask a pharmacist how to safely dispose of unused medicine.
Disclaimer
This information is for educational purposes and does not replace medical advice. Use only as prescribed by a qualified healthcare professional. Always read the label and consult a doctor or pharmacist for diagnosis, dosing, interactions, pregnancy or breastfeeding advice, side effects, overdose or emergency concerns.
| Strength | (10/5Mg) 14 Tablets, (25/5Mg) 14 Tablets |
|---|---|
| Introduction Of Product | Xenglu-Lin 10/5mg Tablets contain empagliflozin 10mg and linagliptin 5mg, a dual oral antidiabetic combination used for adult type 2 diabetes mellitus under physician supervision. |
| Source | Health Wire |
| Key Features | Contains empagliflozin 10mg plus linagliptin 5mg per tablet, Oral antidiabetic combination for type 2 diabetes mellitus, Dual SGLT2 inhibitor and DPP-4 inhibitor mechanism, 14-tablet pack, Use only as directed by a physician |
| Key Benefits | Helps improve glycaemic control in adults with type 2 diabetes, Supports blood glucose management through complementary mechanisms, Can be used with diet and exercise as part of a diabetes care plan, May help reduce long-term diabetes complication risk through improved blood sugar control |
| Primary Uses | Management of type 2 diabetes mellitus in adults, Adjunct to diet and exercise for improved glycaemic control |
| Drug Class | Sodium-glucose co-transporter 2 (SGLT2) inhibitor plus dipeptidyl peptidase-4 (DPP-4) inhibitor |
| Indications | Indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, when considered appropriate by a physician. |
| Used For | Adult type 2 diabetes mellitus and blood glucose control. |
| Suitable For | Adults with type 2 diabetes mellitus when prescribed by a healthcare professional. |
| Who Itu2019s For | Adults who need physician-supervised oral combination therapy for type 2 diabetes management. |
| How It Works | Empagliflozin reduces renal glucose reabsorption and increases glucose excretion in urine. Linagliptin inhibits DPP-4, increasing incretin hormone activity, supporting glucose-dependent insulin release and reducing glucagon secretion. |
| Therapeutic Category | Oral antidiabetic medicine |
| Manufacturer | Hilton Pharma |
| Marketer / Distributor | Hilton Pharma (Pvt) Ltd |
| Country of Origin | Pakistan |
| Prescription Required | Yes |
| Recommended Dose | Use exactly as prescribed by a physician. A common adult regimen for this combination strength is one 10mg/5mg tablet once daily in the morning. |
| How to Use | Swallow the tablet with water. Take at the same time each day, with or without food, and continue prescribed diet, exercise and glucose monitoring. |
| When to Take | Usually once daily in the morning, as directed by the prescribing physician. |
| Maximum Daily Dose | Do not exceed the dose prescribed by your doctor. For the empagliflozin/linagliptin combination, dose increases up to 25mg/5mg once daily may be considered only by a physician. |
| Age Group | Adults |
| Pediatric Use | Safety and effectiveness in children and adolescents have not been established for this combination; use only if specifically prescribed by a specialist. |
| Adult Dose | As prescribed; commonly one 10mg/5mg tablet once daily in the morning. |
| Elderly Use | Use with caution in elderly patients, especially those at risk of dehydration, low blood pressure, kidney impairment or recurrent infections. |
| Missed Dose | Take the missed dose when remembered unless it is close to the next dose. Do not take two doses together to make up for a missed dose; follow your physician’s instructions. |
| Overdose Instructions | Seek medical advice or emergency care immediately. Overdose may require monitoring and supportive treatment, especially for dehydration, low blood pressure, hypoglycaemia or electrolyte imbalance. |
| Before or After Food | May be taken with or without food. |
| Administration Instructions | Oral tablet; swallow whole with water unless advised otherwise by a healthcare professional. |
| Warnings | Not for type 1 diabetes or diabetic ketoacidosis, May increase risk of ketoacidosis, dehydration, urinary infections and genital fungal infections, Risk of hypoglycaemia may increase when combined with insulin or insulin secretagogues, Assess kidney function and hydration status as advised by a doctor |
| Precautions | Inform your doctor about kidney disease, liver disease, heart failure, pancreatitis history, recurrent urinary infections or planned surgery, Maintain adequate hydration unless fluid restriction has been advised, Monitor blood glucose regularly, Report symptoms of urinary infection, genital infection, severe abdominal pain or unusual tiredness promptly |
| Contraindications | Known hypersensitivity to empagliflozin, linagliptin or any tablet ingredient, Use in diabetic ketoacidosis, Severe renal impairment, end-stage renal disease or dialysis unless a specialist advises otherwise |
| When Not to Use | Do not use if allergic to empagliflozin, linagliptin or related ingredients, or for type 1 diabetes or diabetic ketoacidosis. Avoid use without medical review in severe kidney disease or dialysis. |
| Allergy Warning | Stop the medicine and seek urgent help if rash, hives, swelling of the face/lips/tongue/throat, breathing difficulty, skin peeling or severe allergic symptoms occur. |
| Common Side Effects | Increased urination, Thirst, Urinary tract infection, Genital fungal infection, Stuffy or runny nose, Sore throat, Low blood sugar when used with insulin or sulfonylureas |
| Serious Side Effects | Diabetic ketoacidosis, Severe dehydration or low blood pressure, Pancreatitis, Severe urinary tract infection, Fournier’s gangrene, Serious allergic reaction, Severe joint pain, Bullous pemphigoid or blistering skin reaction, Heart failure symptoms, Lower limb infection, ulcers or amputation risk |
| Pregnancy Warning | Use during pregnancy only on medical advice. Diabetes treatment may need specialist adjustment during pregnancy. |
| Breastfeeding Warning | Consult a doctor before use while breastfeeding; the suitability of this combination should be assessed by a healthcare professional. |
| Fertility Warning | No patient-specific fertility information is available for this product; consult a doctor if planning pregnancy. |
| Liver Warning | Use with medical supervision in patients with liver disease or heavy alcohol use. |
| Kidney Warning | Kidney function should be assessed before and during treatment. This medicine may be unsuitable in significant renal impairment or dialysis. |
| Heart Warning | Discuss use with a doctor if you have heart failure, low blood pressure, cardiovascular disease or dehydration risk. |
| Driving or Machine Use Warning | Use caution when driving or operating machinery if dizziness, dehydration or low blood sugar symptoms occur. |
| Alcohol Warning | Limit or avoid alcohol unless your doctor says it is safe, as alcohol may worsen dehydration, hypoglycaemia or ketoacidosis risk. |
| Drug Interactions | Insulin and sulfonylureas may increase hypoglycaemia risk, Diuretics may increase dehydration or low blood pressure risk, Other glucose-lowering medicines may require dose review, Tell your doctor about all prescription, OTC and herbal medicines |
| Food Interactions | No specific food restriction is universally required, but follow the diabetes meal plan advised by your doctor or dietitian. |
| Disease Interactions | Type 1 diabetes, Diabetic ketoacidosis, Renal impairment, Pancreatitis history, Recurrent urinary tract or genital infections, Heart failure, Dehydration or low blood pressure, Planned surgery or prolonged fasting |
| Storage Instructions | Store in a cool, dry place away from direct sunlight, heat and moisture. Keep in original packaging until use. |
| Disposal Instructions | Do not use expired or damaged tablets. Ask a pharmacist how to safely dispose of unused medicine. |
| Keep Away From Children | Keep out of the reach and sight of children. |
| Temperature Requirement | Store at room temperature; avoid excessive heat and moisture. |
| Disclaimer | This information is for educational purposes and does not replace medical advice. Use only as prescribed by a qualified healthcare professional. Always read the label and consult a doctor or pharmacist for diagnosis, dosing, interactions, pregnancy or breastfeeding advice, side effects, overdose or emergency concerns. |
All In One Medicine policy reference: Shipping Policy | Return Policy | Refund Policy
This product may be fulfilled through the source shown below. Source fees, delivery coverage, payment limits, return windows, and refund routes can be stricter than ordinary ecommerce because medicines, prescriptions, cold-chain items, baby products, hygiene goods, and opened products have safety limits.
Shipping & Delivery - Health Wire
Delivery, return, and refund handling
- Healthwire routes medicine orders to the dispensing partner pharmacy that accepts the order.
- Services are restricted to selected territories within Pakistan.
- Prescription medicine ordering is restricted to customers aged 18 or older.
- Delivery time, courier choice, delivery fee, and serviceability are set by the dispensing partner pharmacy and confirmed at order time.
- Healthwire does not publish one unified shipping or return policy for all pharmacy orders.
- The return and refund terms for a medicine order are the actual dispensing partner pharmacy terms.
- Standard pharmacy restrictions still apply to opened, used, prescription, hygiene-sensitive, and temperature-sensitive products.
Related products
-
From: DVAGO
Humalog Mix 25 Kwikpen Injection 100U/Ml (1 Box = 5 Injection)
₨ 2,117Original price was: ₨ 2,117.₨ 2,011Current price is: ₨ 2,011.Add to cart -
From: DVAGO
Vidaylin T Tablets (1 Bottle = 30 Tablets)
₨ 280Original price was: ₨ 280.₨ 266Current price is: ₨ 266.Add to cart -
From: DVAGO
Ryvaq 112Ml Oral Suspension 10Mg/Ml
₨ 800Original price was: ₨ 800.₨ 760Current price is: ₨ 760.Add to cart -
From: DVAGO
Ringolact Infusion 1000Ml
₨ 170Original price was: ₨ 170.₨ 162Current price is: ₨ 162.Add to cart -
From: DVAGO
Venticort Dpi Capsules 200Mg (1 Box = 3 Strips) (1 Strip = 10 Capsules)
₨ 536Original price was: ₨ 536.₨ 510Current price is: ₨ 510.Add to cart






Reviews
There are no reviews yet.